Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1977 Sep;88(3):529–537.

"Prostatic acid phosphatase?" A comparison of acid phosphatase activities in epithelial cells, granulocytes, monocytes, lymphocytes, and platelets purified by velocity sedimentation in isokinetic gradients of Ficoll in tissue culture medium.

S R Helms, M G Brattain, T G Pretlow 2nd, J I Kreisberg
PMCID: PMC2032376  PMID: 560800

Abstract

Numerous investigators have found several substrates and inhibitors to be particularly suited for the demonstration of acid phosphatase of prostatic origin. There has been much controversy over the specificity or lack of specificity of several substrates and inhibitors. We have investigated acid phosphatase activities obtained from several kinds of purified cells. None of the substrates or inhibitors which we studied permitted us to discriminate "prostatic" acid phosphatase from acid phosphatase activities obtained from other kinds of cells.

Full text

PDF
529

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abul-Fadl M. A., King E. J. Properties of the acid phosphatases of erythrocytes and of the human prostate gland. Biochem J. 1949;45(1):51–60. [PMC free article] [PubMed] [Google Scholar]
  2. BABSON A. L., READ P. A. A new assay for prostatic acid phosphatase in serum. Am J Clin Pathol. 1959 Jul;32(1):88–91. doi: 10.1093/ajcp/32.1_ts.88. [DOI] [PubMed] [Google Scholar]
  3. BYRNES W. W., LEMON H. M., REYNOLDS M. D. Copper-resistant serum acid phosphatase. I. Method and values in health and disease. Cancer Res. 1956 Nov;16(10 Pt 1):943–950. [PubMed] [Google Scholar]
  4. CAMPBELL D. M., MOSS D. W. Spectrofluorimetric determination of acid phosphatase activity. Clin Chim Acta. 1961 May;6:307–315. doi: 10.1016/0009-8981(61)90055-9. [DOI] [PubMed] [Google Scholar]
  5. COOK W. B., FISHMAN W. H., CLARKE B. G. Serum acid phosphatase of prostatic origin in the diagnosis of prostatic cancer: clinical evaluation of 2408 tests by the Fishman-Lerner method. J Urol. 1962 Aug;88:281–287. doi: 10.1016/S0022-5347(17)64785-2. [DOI] [PubMed] [Google Scholar]
  6. FISHMAN W. H., DART R. M., BONNER C. D., LEADBETTER W. F., LERNER F., HOMBURGER F. A new method for estimating serum acid phosphatase of prostatic origin applied to the clinical investigation of cancer of the prostate. J Clin Invest. 1953 Oct;32(10):1034–1044. doi: 10.1172/JCI102814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. FISHMAN W. H., LERNER F. A method for estimating serum acid phosphatase of prostatic origin. J Biol Chem. 1953 Jan;200(1):89–97. [PubMed] [Google Scholar]
  8. Gutman A. B., Gutman E. B. AN " ACID " PHOSPHATASE OCCURRING IN THE SERUM OF PATIENTS WITH METASTASIZING CARCINOMA OF THE PROSTATE GLAND. J Clin Invest. 1938 Jul;17(4):473–478. doi: 10.1172/JCI100974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gutman A. B. The development of the acid phosphatase test for prostatic carcinoma: the Sixth Ferdinand C. Valentine Memorial Lecture. Bull N Y Acad Med. 1968 Jan;44(1):63–76. [PMC free article] [PubMed] [Google Scholar]
  10. Helms S. R., Brazeal F. I., Bueschen A. J., Pretlow T. G., 2nd Separation of cells with histochemically demonstrable acid phosphatase activity from suspensions of human prostatic cells in an isokinetic gradient of Ficoll in tissue culture medium. Am J Pathol. 1975 Jul;80(1):79–90. [PMC free article] [PubMed] [Google Scholar]
  11. JACOBSSON K. The determination of tartrate-inhibited phosphatase in serum. Scand J Clin Lab Invest. 1960;12(4):367–380. doi: 10.3109/00365516009065399. [DOI] [PubMed] [Google Scholar]
  12. KAPLAN H. S. New horizons in radiotherapy of malignant disease. J Am Med Assoc. 1959 Sep 12;171:133–138. doi: 10.1001/jama.1959.03010200001001. [DOI] [PubMed] [Google Scholar]
  13. Modder C. P. Investigations on acid phosphatase activity in human plasma and serum. Clin Chim Acta. 1973 Jan 24;43(2):205–214. doi: 10.1016/0009-8981(73)90453-1. [DOI] [PubMed] [Google Scholar]
  14. Murphy G. P., Reynoso G., Kenny G. M., Gaeta J. F. Comparison of total and prostatic fraction serum acid phosphatase levels in patients with differentiated and undifferentiated prostatic carcinoma. Cancer. 1969 Jun;23(6):1309–1314. doi: 10.1002/1097-0142(196906)23:6<1309::aid-cncr2820230611>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  15. OZAR M. B., ISAAC C. A., VALK W. L. Methods for the elimination of errors in serum acid phosphatase determinations. J Urol. 1955 Jul;74(1):150–157. doi: 10.1016/S0022-5347(17)67257-4. [DOI] [PubMed] [Google Scholar]
  16. Pretlow T. G., 2nd, Luberoff D. E. A new method for separating lymphocytes and granulocytes from human peripheral blood using programmed gradient sedimentation in an isokinetic gradient. Immunology. 1973 Jan;24(1):85–92. [PMC free article] [PubMed] [Google Scholar]
  17. Pretlow T. G., 2nd, weir E. E., Zettergren J. G. Problems connected with the separation of different kinds of cells. Int Rev Exp Pathol. 1975;14:91–204. [PubMed] [Google Scholar]
  18. Seal U. S., Mellinger G. T., Doe R. P. A study of phenyl phosphate and alpha-naphthyl phospate as substrates for serum acid phosphatases. Clin Chem. 1966 Sep;12(9):620–631. [PubMed] [Google Scholar]
  19. Seligman A. M., Sternberger N. J., Paul B. D., Friedman A. E., Shannon W. A., Jr, Wasserkrug H. L., Plapinger R. E., Lynm D. Design of spindle poisons activated specifically by prostatic acid phosphatase (PAP) and new methods for PAP cytochemistry. Cancer Chemother Rep. 1975 Jan-Feb;59(1):233–242. [PubMed] [Google Scholar]
  20. Yam L. T. Clinical significance of the human acid phosphatases: a review. Am J Med. 1974 May;56(5):604–616. doi: 10.1016/0002-9343(74)90630-5. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES